Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy

✍ Scribed by Lentz, S. R.; Misgav, M.; Ozelo, M.; Šalek, S. Z.; Veljkovic, D.; Recht, M.; Cerqueira, M.; Tiede, A.; Brand, B.; Mancuso, M. E.; Seremetis, S.; Lindblom, A.; Martinowitz, U.

• Book ID: 121646639
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 214 KB
• Volume: 19
• Category: Article
• ISSN: 1351-8216
• DOI: 10.1111/hae.12159